You walk into an electronics store in New York, pick up a brand-new smartphone, and flip it over. The fine print says “Made in India.” That label, unthinkable five years ago, is now a quiet rerating machine working its way through Indian manufacturing stocks — and the PLI scheme’s latest data dump confirms the trend is accelerating into 2026.
For anyone tracking sectoral momentum with a 3-to-6-month lens, the fresh numbers paint a clear picture of where production is actually ramping, where order books are swelling, and where the next round of policy catalysts might land.
The numbers that reset the narrative
As of December 31, 2025, PLI schemes across 14 sectors had drawn ₹2.16 lakh crore in actual investments. Cumulative sales crossed ₹20.41 lakh crore, exports touched ₹8.3 lakh crore, and the government disbursed ₹28,748 crore in incentives. On the ground, 14.39 lakh direct and indirect jobs signal real factory floors, not just approval letters.
The Economic Survey 2025-26 confirms electronics is the flagbearer. Smartphone exports hit $30 billion in CY2025. Mobile phone imports collapsed 77% since FY21, and over 99% of domestic demand is met locally. This is no longer import substitution — it’s an export engine scaling fast.
Pharma runs parallel: PLI-linked sales crossed ₹2.66 lakh crore in three years, exports reached ₹1.7 lakh crore, and domestic value addition hit 83.7% by March 2025.
Stocks where the PLI order flow is most visible
Dixon Technologies remains the EMS anchor of the mobile-phone PLI. The stock has tested the ₹15,700 zone three times in recent months and pulled back each time. The next quarterly result, due in late May, typically brings order-book commentary that has moved the stock 6–8% in a single session in the past. Market participants are watching whether volume patterns shift around that resistance level following the earnings call.
Bharat Forge sits at the center of the auto PLI ecosystem, which has absorbed ₹35,600 crore in cumulative investments. The stock is currently near ₹1,105, with an observable support cluster around ₹1,030. Monthly auto sales data — released in the first week of every month — tends to act as a leading signal for component order books with a 4–6 week lag. The ₹1,150 level has functioned as a pivot in prior cycles.
Sun Pharma and Dr. Reddy’s are benefiting from PLI-linked import substitution: 191 bulk drugs manufactured domestically for the first time, saving ₹1,785 crore. The cost advantage shows up as a tailwind on quarterly margins. A less obvious catalyst: US FDA approvals for India-based plants built under PLI capacity. The FDA’s warning-letter database is publicly searchable, and resolution of outstanding facility issues has historically preceded fresh export-driven re-ratings in these names.
Aarti Industries and PI Industries capture the specialty-chemical leg of China-plus-one. Aarti is near ₹520, with a visible support floor around ₹490. The relationship between crude oil prices and their input costs is well documented — a sustained dip in crude tends to expand operating margins with a two-quarter lag. Traders often cross-check crude levels before positioning in this pocket.
The policy catalyst on the horizon
The original mobile-phone PLI’s six-year tenure approaches its March 2026 deadline. A successor scheme or “PLI 2.0” top-up is widely anticipated, possibly in the FY27 Budget cycle. The commerce ministry’s quarter-end PLI review meetings — minutes often appear on the PIB website — have historically served as early indicators of policy direction. The entire EMS pack (Dixon, Amber Enterprises, Syrma SGS) has shown high correlation to such announcements.
Watching the sector in motion
The manufacturing theme is tracked in real time through the Nifty India Manufacturing Index. Two ETFs provide passive exposure — the Nippon India Nifty India Manufacturing ETF (NAV: ₹140.39 as of March 30, 2026, expense ratio 0.25%) and the Mirae Asset Nifty India Manufacturing ETF FoF. Their daily NAV movements mirror the sector’s intraday momentum, making them useful tracking tools even for those not taking a position.
Where the tension sits right now
Dixon’s Q4 numbers land in late May. The stock is sitting near ₹15,200, with ₹15,700 as the observed resistance that hasn’t been closed above in prior attempts. Bharat Forge is watching ₹1,150 on the weekly chart. The crude-oil trajectory — visible on any commodities heatmap — feeds directly into chemical-margin assumptions. No predictions, just the levels and dates that previous market reactions have clustered around. The rest is your read.